Playlist

Young Engineer 2026 Competition Concludes in Turkmenistan

27 Apr. 11:18

Source

The "Young Engineer 2026" competition recently took place in Ashgabat, bringing together nearly 200 students from across Turkmenistan. Held at the facilities of the "Ojar Asia" private enterprise, the event provided a platform for students in grades 7 through 12 to showcase their technical expertise. The participants competed in various formats, highlighting their abilities in both individual and collaborative engineering projects.

Winners were selected in several specialized categories that reflect current technological trends. In the field of smart production and service technologies, students from the Ashgabat International School secured the top spots. Meanwhile, participants from specialized schools in the capital and the Balkan region excelled in robotics, programming, and the highly competitive "BattleBots" category, demonstrating advanced logical and mechanical skills.

A significant outcome of this event is the selection of a national team for upcoming international engagements. The top five performers in the robotics category have earned the opportunity to represent Turkmenistan at the "First Global Challenge 2026" world championship. This follow-up success comes after the Turkmen student delegation achieved victory in the "Skills Challenge" category during last year's global forum in Panama.

The competition was co-organized by the Ashgabat committees of the Industrialists and Entrepreneurs Party, the Ministry of Education, and the Magtymguly Youth Organization. According to the organizers, these events are instrumental in advancing educational reforms and fostering innovation among the youth. The initiative aims to provide students with the necessary tools and recognition to thrive in a rapidly evolving digital and industrial landscape.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌